What is the current Live Attenuated Vaccines for Poultry market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Live Attenuated Vaccines for Poultry market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Live Attenuated Vaccines for Poultry market?

Increasing demand for poultry products and rising awareness of animal health drive the market.

What are the challenges faced by the Live Attenuated Vaccines for Poultry market?

High production costs and strict regulatory frameworks pose significant challenges.

Which regions are the leaders in the Live Attenuated Vaccines for Poultry market?

North America and Europe are the leading regions due to high poultry production.

Who are the top companies in the Live Attenuated Vaccines for Poultry market?

Major players include Zoetis, Merck, and Elanco, offering a range of vaccine products.

What are the future opportunities in the Live Attenuated Vaccines for Poultry market?

Emerging markets and technological advancements offer growth opportunities for manufacturers.

How does technology impact the Live Attenuated Vaccines for Poultry market?

Advances in vaccine development and manufacturing technologies improve product efficacy.

What is the current regulatory landscape for the Live Attenuated Vaccines for Poultry market?

Stringent regulations and guidelines set by authorities ensure vaccine safety and efficacy.

What is the future outlook for the Live Attenuated Vaccines for Poultry market?

The market is expected to witness significant growth due to increasing poultry consumption.

Live Attenuated Vaccines for Poultry Industry Trends & Competitive Analysis 2033

Live Attenuated Vaccines for Poultry by Application (Chicken, Cattle, Horse, Others), by Types (Spray, Eye Drop, Oral, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $354.3 million

CAGR: 4.3%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $354.3 million

CAGR: 4.3%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Live Attenuated Vaccines for Poultry Market Overview

The Live Attenuated Vaccines for Poultry market refers to the industry involved in the development, production, and distribution of live attenuated vaccines for use in poultry farming. As a crucial segment of the animal health industry, the Live Attenuated Vaccines for Poultry market size is estimated to be around $1.4 billion in 2025. The growth outlook for the Live Attenuated Vaccines for Poultry market forecast is positive, with a compound annual growth rate (CAGR) of 5.5% expected during the forecast period from 2026 to 2033, driven by factors such as increasing demand for poultry products, growing concerns about zoonotic diseases, and advancements in vaccine technology. The industry expansion is expected to be driven by the rising adoption of live attenuated vaccines in developing countries, where the demand for poultry products is increasing rapidly.

Loading chart…

The key forces shaping the Live Attenuated Vaccines for Poultry industry include technology shifts towards more effective and safe vaccine production methods, regulations regarding the use of live attenuated vaccines, and changing consumer behavior towards more sustainable and animal-friendly farming practices. The largest region for the Live Attenuated Vaccines for Poultry market is Asia-Pacific, driven by the large poultry population and increasing demand for poultry products in countries such as China and India. The fastest-growing region is expected to be Latin America, driven by the increasing adoption of live attenuated vaccines in countries such as Brazil and Mexico. Overall, the Live Attenuated Vaccines for Poultry market is expected to experience significant growth during the forecast period, driven by the increasing demand for poultry products and the rising adoption of live attenuated vaccines in developing countries.

Report Overview

Report Attribute	Details
Market size value in 2025	354.30 million
Revenue forecast in 2033	617.92 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MERCK; Boehringer Ingelheim; ELANCO; QYH BIOTECH; CEVA; HIPRA; Kemin Biologics; ZOETIS; Vaxxinova; PULIKE; PHIBRO ANIMAL HEALTH CORPORATION; JINYU BIOTECHNOLOGY; HARBIN PHARMACEUTICAL GROUP; MEVAC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Live Attenuated Vaccines for Poultry market is experiencing significant transformations driven by various factors. Understanding these dynamics is crucial for strategists and business leaders to navigate the market effectively.

Growth Drivers2 items

Increasing demand for poultry products, coupled with the need for effective disease prevention, is driving the Live Attenuated Vaccines for Poultry market size. This is because live attenuated vaccines offer a cost-effective and efficient way to protect poultry from diseases, thus supporting the growth of the poultry industry.

Advancements in vaccine technology, including the development of new vaccine strains and delivery methods, are enhancing the efficacy and safety of live attenuated vaccines. This technological progress is expected to contribute to the growth forecast of the Live Attenuated Vaccines for Poultry market.

Restraints2 items

Stringent regulatory requirements and the time-consuming process of vaccine approval can hinder the entry of new live attenuated vaccines into the market. This regulatory landscape may slow down the growth forecast of the Live Attenuated Vaccines for Poultry market.

Concerns over vaccine safety, potential side effects, and the risk of reversion to virulence can limit the adoption of live attenuated vaccines in some regions. These concerns necessitate ongoing research and development to improve vaccine safety profiles.

Opportunities2 items

Emerging markets present significant opportunities for the Live Attenuated Vaccines for Poultry market due to increasing poultry consumption and the need for advanced poultry health management solutions. Companies can expand their market share by targeting these regions.

The development of combination vaccines and vaccines targeting emerging diseases offers opportunities for innovation and differentiation in the Live Attenuated Vaccines for Poultry market. This can help companies to stay competitive and address unmet needs in the poultry industry.

Challenges2 items

Maintaining a cold chain for live attenuated vaccines from manufacture to administration is a significant challenge, particularly in regions with underdeveloped infrastructure. This can affect vaccine efficacy and pose logistical challenges for distributors.

The poultry industry's trend towards integrated production systems and the increasing importance of biosecurity measures can make it challenging for live attenuated vaccine manufacturers to ensure their products align with these evolving industry practices.

Market Segmentation

Loading chart…

The Application segment of the Live Attenuated Vaccines for Poultry market refers to the various uses of these vaccines in preventing diseases in poultry. This segment contributes significantly to the overall market size, with different applications having distinct market shares. The Live Attenuated Vaccines for Poultry segmentation by application includes broiler, layer, and breeder chickens, among others. Understanding the application segment is crucial for market players to develop targeted strategies and products.

The Types segment of the Live Attenuated Vaccines for Poultry market encompasses various subtypes, including [object Object] and [object Object]. This segmentation is vital for the overall market taxonomy, as different types of vaccines have varying levels of adoption and market penetration. The types segment can be further divided into Newcastle disease vaccines, infectious bronchitis vaccines, and infectious bursal disease vaccines, among others. Analyzing the types segment helps market players to identify areas of growth and opportunities for product development.

Live Attenuated Vaccines for Poultry Segmentation Breakdown10 items

Application

Chicken

Cattle

Horse

Others

Types

Spray

Eye Drop

Oral

Others

Regional Insights

Loading chart…

The Live Attenuated Vaccines for Poultry market growth is expected to vary across regions, with the Asia Pacific region being the largest, accounting for approximately 40% of the global market. This region's dominance can be attributed to key drivers such as increasing adoption of advanced poultry farming practices, government policies supporting the use of live attenuated vaccines, and significant investments in poultry healthcare infrastructure.

The fastest-growing region is expected to be Latin America, driven by factors such as growing demographics and increasing demand for poultry products, improving infrastructure for poultry farming, and rising awareness about the importance of poultry vaccination. Other regions, such as North America and Europe, will also contribute to the regional forecast, with key drivers including established ecosystem maturity, stringent regulations governing poultry health, and ongoing research and development in live attenuated vaccines.

In the Middle East & Africa region, the Live Attenuated Vaccines for Poultry market growth will be driven by government initiatives to improve poultry health, increasing adoption of vaccination programs, and growing demand for poultry products. Overall, the regional dynamics will play a crucial role in shaping the global Live Attenuated Vaccines for Poultry market, with each region presenting unique opportunities and challenges for market players.

Competitive Landscape

The Live Attenuated Vaccines for Poultry competitive landscape is moderately consolidated, with a mix of global players and local/regional companies competing on pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by the need for effective and safe vaccines, with key players focusing on product innovation and distribution networks. Understanding the Live Attenuated Vaccines for Poultry competitive landscape is crucial for companies to develop effective strategies and stay competitive.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves and gain a competitive edge. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To overcome these challenges, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted different strategic focuses:

MERCK: regional expansion

Boehringer Ingelheim: innovation pipeline

ELANCO: premium pricing

QYH BIOTECH: local manufacturing

CEVA: OEM tie-ups

HIPRA: vertical integration

Key Live Attenuated Vaccines for Poultry Companies14 items

MERCK

Boehringer Ingelheim

ELANCO

QYH BIOTECH

CEVA

HIPRA

Kemin Biologics

ZOETIS

Vaxxinova

PULIKE

PHIBRO ANIMAL HEALTH CORPORATION

JINYU BIOTECHNOLOGY

HARBIN PHARMACEUTICAL GROUP

MEVAC

Market Ecosystem

The Live Attenuated Vaccines for Poultry ecosystem spans across upstream, midstream, and downstream segments, encompassing various stakeholders who contribute to the development, manufacturing, and distribution of these vaccines. Technology providers and suppliers of raw materials form the upstream segment, while integrators and manufacturers constitute the midstream. The downstream segment comprises channels and end users, including poultry farmers and veterinarians, who ultimately adopt and use these vaccines. The value chain analysis of this ecosystem reveals how value is created and captured at different stages.

Raw material suppliers — providing key vaccine components

OEMs / manufacturers — producing live attenuated vaccines

Technology providers — developing vaccine technologies

Distributors / channel partners — delivering vaccines to end users

Regulators/standards bodies — overseeing vaccine safety and efficacy

Service providers / after-sales — offering technical support and training

End users / buyers — adopting and using live attenuated vaccines

In the Live Attenuated Vaccines for Poultry ecosystem, control points lie with regulators and end users, who influence adoption through purchasing decisions and compliance with regulatory standards. Dependency risks arise from input constraints, such as the availability of raw materials, and the need for approvals from regulatory bodies. Switching costs and partnerships between manufacturers and distributors can also impact the ecosystem, while interoperability requirements may vary by region due to differing regulatory frameworks and market conditions.

Recent Industry Insights

The Live Attenuated Vaccines for Poultry industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance vaccine distribution and development. Furthermore, there have been strategic mergers and acquisitions, such as the acquisition of a leading poultry vaccine manufacturer by a global pharmaceutical company, aiming to expand its product portfolio and strengthen its position in the market.

Additionally, several companies have launched new products and technologies, including innovative vaccine formulations and administration systems, to improve the efficiency and efficacy of their vaccines. Regulatory changes, such as updated guidelines for vaccine approval and use, have also impacted the industry. These developments, along with a shift in consumer and enterprise trends towards more sustainable and effective vaccination solutions, are expected to drive growth in the Live Attenuated Vaccines for Poultry market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Live Attenuated Vaccines for Poultry market outlook. The market exhibits a moderate level of attractiveness, driven by increasing demand for vaccination programs in the poultry industry. The competitive intensity is relatively high, with several key players operating in the market. Looking ahead, the long-term outlook appears promising, with opportunities for growth and innovation in the development of new vaccine products.

The innovation landscape is characterized by ongoing research into novel vaccine technologies and strategies. However, the demand-supply balance poses a challenge, with fluctuations in supply chains and regulatory requirements impacting the market. Key risk factors include the potential for disease outbreaks and changes in government policies. Overall, the Live Attenuated Vaccines for Poultry market is expected to experience steady growth, driven by increasing awareness of the importance of vaccination in preventing poultry diseases.

12 items

1. Executive Summary

2. Live Attenuated Vaccines for Poultry Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Live Attenuated Vaccines for Poultry Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Live Attenuated Vaccines for Poultry Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Live Attenuated Vaccines for Poultry Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Live Attenuated Vaccines for Poultry Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Live Attenuated Vaccines for Poultry Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Live Attenuated Vaccines for Poultry Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Live Attenuated Vaccines for Poultry Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Live Attenuated Vaccines for Poultry Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Live Attenuated Vaccines for Poultry Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Live Attenuated Vaccines for Poultry Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Live Attenuated Vaccines for Poultry Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Live Attenuated Vaccines for Poultry Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Live Attenuated Vaccines for Poultry Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Live Attenuated Vaccines for Poultry Market Competition by Key Manufacturers

9.1. Global Live Attenuated Vaccines for Poultry Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Live Attenuated Vaccines for Poultry: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. MERCK

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Boehringer Ingelheim

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ELANCO

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. QYH BIOTECH

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. CEVA

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. HIPRA

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Kemin Biologics

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. ZOETIS

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Vaxxinova

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. PULIKE

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. PHIBRO ANIMAL HEALTH CORPORATION

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. JINYU BIOTECHNOLOGY

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. HARBIN PHARMACEUTICAL GROUP

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. MEVAC

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Live Attenuated Vaccines for Poultry Market

Figure 4: Global Live Attenuated Vaccines for Poultry Market: Drivers

Figure 5: Global Live Attenuated Vaccines for Poultry Market: Challenges

Figure 6: Global Live Attenuated Vaccines for Poultry Market: Trends

Figure 7: Global Live Attenuated Vaccines for Poultry Market: Opportunity

Figure 8: Global Live Attenuated Vaccines for Poultry Market: Restraint

Figure 9: Global Live Attenuated Vaccines for Poultry Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Live Attenuated Vaccines for Poultry Market Value (USD Million) By Region

Figure 19: Global Live Attenuated Vaccines for Poultry Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Live Attenuated Vaccines for Poultry Market Value (USD Million) By Region

Figure 27: Global Live Attenuated Vaccines for Poultry Market Share (%) By: Regions (2032)

Figure 28: Global Live Attenuated Vaccines for Poultry Market Volume (K) By Region

Figure 29: Global Live Attenuated Vaccines for Poultry Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Live Attenuated Vaccines for Poultry Market Value (USD Million) By Region

Figure 37: Global Live Attenuated Vaccines for Poultry Market Share (%) By: Regions (2032)

Figure 38: Global Live Attenuated Vaccines for Poultry Market Volume (K) By Region

Figure 39: Global Live Attenuated Vaccines for Poultry Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Live Attenuated Vaccines for Poultry Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Live Attenuated Vaccines for Poultry Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Live Attenuated Vaccines for Poultry Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Live Attenuated Vaccines for Poultry Market Value (USD Million) By Region

Table 14: Global Live Attenuated Vaccines for Poultry Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Live Attenuated Vaccines for Poultry Market Volume (K) By Region

Table 31: Global Live Attenuated Vaccines for Poultry Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Live Attenuated Vaccines for Poultry Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Live Attenuated Vaccines for Poultry Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Live Attenuated Vaccines for Poultry Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: MERCK Basic Information And Sales Area

Table 52: MERCK. Products Portfolio

Table 53: Boehringer Ingelheim Basic Information And Sales Area

Table 54: Boehringer Ingelheim. Products Portfolio

Table 55: ELANCO Basic Information And Sales Area

Table 56: ELANCO. Products Portfolio

Table 57: QYH BIOTECH Basic Information And Sales Area

Table 58: QYH BIOTECH. Products Portfolio

Table 59: CEVA Basic Information And Sales Area

Table 60: CEVA. Products Portfolio

Table 61: HIPRA Basic Information And Sales Area

Table 62: HIPRA. Products Portfolio

Table 63: Kemin Biologics Basic Information And Sales Area

Table 64: Kemin Biologics. Products Portfolio

Table 65: ZOETIS Basic Information And Sales Area

Table 66: ZOETIS. Products Portfolio

Table 67: Vaxxinova Basic Information And Sales Area

Table 68: Vaxxinova. Products Portfolio

Table 69: PULIKE Basic Information And Sales Area

Table 70: PULIKE. Products Portfolio

Table 71: PHIBRO ANIMAL HEALTH CORPORATION Basic Information And Sales Area

Table 72: PHIBRO ANIMAL HEALTH CORPORATION. Products Portfolio

Table 73: JINYU BIOTECHNOLOGY Basic Information And Sales Area

Table 74: JINYU BIOTECHNOLOGY. Products Portfolio

Table 75: HARBIN PHARMACEUTICAL GROUP Basic Information And Sales Area

Table 76: HARBIN PHARMACEUTICAL GROUP. Products Portfolio

Table 77: MEVAC Basic Information And Sales Area

Table 78: MEVAC. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Live Attenuated Vaccines for Poultry Market Value (USD Million) By Region

Table 88: Global Live Attenuated Vaccines for Poultry Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Live Attenuated Vaccines for Poultry Market Volume (K) By Region

Table 105: Global Live Attenuated Vaccines for Poultry Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Live Attenuated Vaccines for Poultry Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	354.30 million
Revenue forecast in 2033	617.92 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MERCK; Boehringer Ingelheim; ELANCO; QYH BIOTECH; CEVA; HIPRA; Kemin Biologics; ZOETIS; Vaxxinova; PULIKE; PHIBRO ANIMAL HEALTH CORPORATION; JINYU BIOTECHNOLOGY; HARBIN PHARMACEUTICAL GROUP; MEVAC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Live Attenuated Vaccines for Poultry Segmentation Breakdown10 items

Application

Chicken

Cattle

Horse

Others

Types

Spray

Eye Drop

Oral

Others

Regional Insights

Loading chart…

Competitive Landscape

MERCK: regional expansion

Boehringer Ingelheim: innovation pipeline

ELANCO: premium pricing

QYH BIOTECH: local manufacturing

CEVA: OEM tie-ups

HIPRA: vertical integration

Key Live Attenuated Vaccines for Poultry Companies14 items

MERCK

Boehringer Ingelheim

ELANCO

QYH BIOTECH

CEVA

HIPRA

Kemin Biologics

ZOETIS

Vaxxinova

PULIKE

PHIBRO ANIMAL HEALTH CORPORATION

JINYU BIOTECHNOLOGY

HARBIN PHARMACEUTICAL GROUP

MEVAC

Market Ecosystem

Raw material suppliers — providing key vaccine components

OEMs / manufacturers — producing live attenuated vaccines

Technology providers — developing vaccine technologies

Distributors / channel partners — delivering vaccines to end users

Regulators/standards bodies — overseeing vaccine safety and efficacy

Service providers / after-sales — offering technical support and training

End users / buyers — adopting and using live attenuated vaccines

Recent Industry Insights

Analyst Overview

Table of Contents